Koike Y, Magnusson A, Steiner E, Rane A, Sjöqvist F
Ther Drug Monit. 1985;7(4):461-5. doi: 10.1097/00007691-198512000-00018.
Protein binding of phenytoin (PHT) was studied in 36 patients with normal kidney function and six uremic patients. We compared a newly introduced ultrafiltration (UF) technique (EMIT Free Level System I) for measuring unbound PHT in plasma with an equilibrium dialysis (ED) method. The precision of the UF method was satisfactory (the CV within samples was 4.2%, and between days, 3.4%). PHT concentrations were measured with both homogeneous enzyme immunoassay and high performance liquid chromatography using plasma samples from epileptic patients. The values obtained agreed well. Unbound concentrations of PHT determined by the UF technique and ED were identical in both normal and uremic plasma obtained from patients under treatment. Unbound concentrations of PHT correlated significantly to total concentrations in both groups of patients. The investigated UF technique thus appears to be accurate for measuring unbound concentrations of PHT in plasma. Controlled clinical studies are required to show that this is a cost-effective clinical service.
在36例肾功能正常的患者和6例尿毒症患者中研究了苯妥英(PHT)的蛋白结合情况。我们将一种新引入的用于测量血浆中游离PHT的超滤(UF)技术(EMIT游离水平系统I)与平衡透析(ED)方法进行了比较。UF方法的精密度令人满意(样本内CV为4.2%,不同日期间为3.4%)。使用癫痫患者的血浆样本,通过均相酶免疫测定法和高效液相色谱法测量PHT浓度。所得值吻合良好。通过UF技术和ED测定的PHT游离浓度在接受治疗患者的正常和尿毒症血浆中均相同。两组患者中,PHT的游离浓度与总浓度均显著相关。因此,所研究的UF技术似乎对于测量血浆中PHT的游离浓度是准确的。需要进行对照临床研究以证明这是一种具有成本效益的临床服务。